ロード中...
Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery
Roux-en-Y Gastric bypass surgery (RYGB) is emerging as a powerful tool for treatment of obesity and may also cause remission of type 2 diabetes. However, the molecular mechanism of RYGB leading to diabetes remission independent of weight loss remains elusive. In this study, we profiled plasma metabo...
保存先:
| 出版年: | EBioMedicine |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5835566/ https://ncbi.nlm.nih.gov/pubmed/29422288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.01.018 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|